Riskpilot← Back to searchSign inGet full accessCARDIACCS AS
ASActiveOrg 994338668Gaustadalléen 21, 0349 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20095 employees
Revenue 2024
NOK 355K
-87% vs 2023
EBITDA margin
-1185.3%
+29% vs 2023
Equity ratio
56.4%
Financial strength
Net profit 2024
NOK -4,5M
+36% vs 2023
| Revenue | NOK 355K | -87% |
| EBITDA | NOK -4,2M | +29% |
| Net profit | NOK -4,5M | +36% |
| Total assets | NOK 2,6M | -71% |
| Equity | NOK 1,5M | -75% |
| Employees | 5 | — |
Legal name
CARDIACCS AS
Org number
994338668
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25. juli 2009
Share capital
NOK 1 448 160
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Omfatte direkte eller indirekte å drive virksomhet innenfor utvikling av teknologibaserte produkter primært for medisinsk anvendelse.
Address
Gaustadalléen 21, 0349 Oslo
Phone
+4797071849
Email
post@cardiaccs.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 454 | 5 147 | 7 883 | 2 669 | 355 |
| Staff expenses | −3 383 | −4 342 | −4 979 | −4 306 | −1 960 |
| EBITDA | −825 | −1 853 | −42 | −5 942 | −4 211 |
| Depreciation & amort. | −111 | −785 | −2 269 | −1 967 | −431 |
| EBIT | −936 | −2 638 | −2 311 | −7 909 | −4 643 |
| Net financials | −276 | −332 | −53 | 861 | 135 |
| Profit before tax | −1 212 | −2 970 | −2 365 | −7 047 | −4 508 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 212 | −2 970 | −2 365 | −7 047 | −4 508 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 620 | 21 885 | 18 275 | 8 872 | 2 612 |
| Equity | 7 157 | 11 617 | 11 799 | 5 981 | 1 473 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 463 | 9 831 | 6 475 | 2 891 | 1 139 |
| Total debt | 5 463 | 9 831 | 6 475 | 2 891 | 1 139 |
EBITDA margin
-1185.3%
This company
15.8%
Market median
-7602% vs market
20202024
Equity ratio
56.4%
This company
38.2%
Market median
+48% vs market
20202024
Return on equity
-306.1%
This company
18.4%
Market median
-1764% vs market
20202024
Net profit margin
-1268.8%
This company
8.1%
Market median
-15764% vs market
20202024
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20202024
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2023 | |
| Former (4) | ||
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 6.03% | 6.03% | 2023 | |
| Individual | 4.89% | 4.89% | 2023 | |
| Company | 4.43% | 4.43% | 2023 | |
| Individual | 3.45% | 3.45% | 2023 | |
| Company | 3.37% | 3.37% | 2023 | |
| Company | 3.18% | 3.18% | 2023 | |
| Company | 2.96% | 2.96% | 2023 | |
| Company | 2.42% | 2.42% | 2023 | |
| Individual | 2.25% | 2.25% | 2023 | |
| Individual | 2.18% | 2.18% | 2022 | |
| Individual | 2.13% | 2.13% | 2023 | |
| Company | 2.13% | 2.13% | 2023 | |
| Company | 1.77% | 1.77% | 2023 | |
| Company | 1.76% | 1.76% | 2023 | |
| Individual | 1.73% | 1.73% | 2023 | |
| Company | 1.58% | 1.58% | 2023 | |
| Individual | 1.45% | 1.45% | 2023 | |
| Company | 1.41% | 1.41% | 2023 | |
| Company | 1.38% | 1.38% | 2023 | |
| Company | 1.38% | 1.38% | 2023 | |
| Individual | 1.31% | 1.31% | 2023 | |
| Company | 1.21% | 1.21% | 2023 | |
| Company | 1.14% | 1.14% | 2023 | |
| Company | 1.1% | 1.1% | 2023 | |
| Individual | 1.08% | 1.08% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CARDIACCS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Lothe | Board of Directors | 0 companies |
| Magnus Reinsfelt Krogh | Board of Directors | 0 companies |
| Carl Christian Gilhuus-Moe | Board of Directors | 0 companies |
| Tine Borgen Hildisch | Board of Directors | 0 companies |
| Mikkel Drolsum Finstad | Board of Directors | 0 companies |
| Erik Torgeir Fosse | Chairman | 0 companies |